Akoya Biosciences Inc (AKYA)
3.82
+0.01
(+0.26%)
USD |
NASDAQ |
Apr 25, 16:00
3.82
0.00 (0.00%)
Pre-Market: 20:00
Akoya Biosciences Total Liabilities (Quarterly): 126.60M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 126.60M |
| September 30, 2023 | 115.27M |
| June 30, 2023 | 116.98M |
| March 31, 2023 | 112.17M |
| December 31, 2022 | 117.45M |
| September 30, 2022 | 101.37M |
| June 30, 2022 | 93.41M |
| Date | Value |
|---|---|
| March 31, 2022 | 80.58M |
| December 31, 2021 | 69.56M |
| September 30, 2021 | 58.02M |
| June 30, 2021 | 58.52M |
| March 31, 2021 | 134.48M |
| December 31, 2020 | 128.69M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
58.02M
Minimum
Sep 2021
134.48M
Maximum
Mar 2021
101.01M
Average
112.17M
Median
Mar 2023
Total Liabilities (Quarterly) Benchmarks
| Bruker Corp | 2.837B |
| Azenta Inc | 380.65M |
| Harvard Bioscience Inc | 64.29M |
| Bionano Genomics Inc | 118.25M |
| Singular Genomics Systems Inc | 86.46M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 180.37M |
| Shareholders Equity (Quarterly) | 53.77M |
| Debt to Equity Ratio | 1.400 |
| Current Ratio | 3.446 |
| Net Debt Paydown Yield | -1.88% |